RE:RE:RE:New job posting If they have indeed idenfied less than strict adherence to stringent clinial and pre clinical methods and procedires and reporting etc that could be good news in the sense that they might be able to pivot and come up with corrective measures /
As I said before going from a strictky HIV focused company and overnight improvising to become a company involved in research in oncollogy with no experienced staff and no organisational structure to properly support these activities is bound to be a recipe for failure.....This new position is a demonstration of that flawed structure....
.
SPCEO1 wrote: That reads to me like an indictment of Christian. Perhaps on further review, the great preclinical work may have had some flaws? Or, it could be they found protocols were not being followed in the phase 1a and 1b leading to the pause due to weird results. There clearly is a big gap between the preclinical results and the still unknown phase 1a and 1b results, so I am sure they are trying to figure that out.
scarlet1967 wrote: "Audit activities to ensure that Theratechnologies pre-clinical and clinical studies are conducted according to protocols and that any deviation is documented and assessed"
THTX isn't involved with any preclinical studies but Sort1!!